Ralph Wong

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2008 · 3K citations · Full text

Medicine, Oncology, Pharmacology +12

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

Stephanie Yasmin Brule, Derek J. Jonker, Christos S. Karapetis et al. · European Journal of Cancer · 2015 · 337 citations

Medicine, Oncology, Surgery +13

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Kerry S. Courneya, Janette L. Vardy, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2025 · 256 citations

Medicine, Health Education, Oncology +17

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio et al. · Journal of Clinical Oncology · 2023 · 243 citations

Medicine, Oncology, Pharmacology +12

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

J Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio et al. · British Journal of Cancer · 2011 · 227 citations · Full text

Medicine, Oncology, Pharmacology +13